Product Information
LEVSIN 0.125 MG TABLET is a brand product labeled by Viatris Specialty LLC, priced at $2.6559 per EA under NDC 68220011210. Its NADAC has been published 42 times since Dec 17, 2025.
The High Outlier badge above means this manufacturer's average price in the hyoscyamine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.125 mg/1
Manufacturer
Viatris Specialty LLCNDC
68220011210
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYOSCYAMINE SULFATEApproval Type
Unapproved
On Market Since
6/1/1955
Price Statistics
The NADAC for LEVSIN 0.125 MG TABLET has been published 42 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6559 per EA |
|---|---|
| All-time high | $2.6566 (Sep 16, 2026) |
| All-time low | $2.6521 (Dec 17, 2025) |
| 52-week high | $2.6566 |
| 52-week low | $2.6521 |
| Median price | $2.6530 |
| Average price | $2.6534 |
| Largest weekly change | +0.1% (Aug 19, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hyoscyamine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVSIN 0.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVSIN 0.125 MG TABLET, manufactured by Viatris Specialty LLC, is $2.6559 per EA (NDC 68220011210), effective Sep 30, 2026.
How has the price of LEVSIN 0.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVSIN 0.125 MG TABLET has held within roughly two percent of its current level. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for LEVSIN 0.125 MG TABLET?
Since Dec 17, 2025, the NADAC for LEVSIN 0.125 MG TABLET has ranged from a low of $2.6521 (Dec 17, 2025) to a high of $2.6566 (Sep 16, 2026), with a median of $2.6530 per EA.
Are there cheaper alternatives to LEVSIN 0.125 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYOSCYAMINE 0.125 MG ODT, is $0.1442 per EA — about 95% below LEVSIN 0.125 MG TABLET.
Who manufactures LEVSIN 0.125 MG TABLET?
LEVSIN 0.125 MG TABLET (NDC 68220011210) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.